Solomayer E - Search Results

1

Evaluation of ERalpha, PR and ERbeta isoforms in neoadjuvant treated breast cancer.

Wurster M, Ruoff A, Meisner C, Seeger H, Vogel U, Juhasz-Böss I, Solomayer E, Wallwiener D, Fehm T, Neubauer H. Wurster M, et al. Among authors: solomayer e. Oncol Rep. 2010 Sep;24(3):653-9. Oncol Rep. 2010. PMID: 20664970

2

Changes in tumour biological markers during primary systemic chemotherapy (PST).

Neubauer H, Gall C, Vogel U, Hornung R, Wallwiener D, Solomayer E, Fehm T. Neubauer H, et al. Among authors: solomayer e. Anticancer Res. 2008 May-Jun;28(3B):1797-804. Anticancer Res. 2008. PMID: 18630463 Free article.

3

A laminin-rich basement membrane matrix influences estrogen receptor beta expression and morphology of MDA-MB-231 breast cancer cells.

Neubauer H, Ruoff A, Paessler N, Solomayer E, Wallwiener D, Fehm T. Neubauer H, et al. Among authors: solomayer e. Oncol Rep. 2009 Feb;21(2):475-81. Oncol Rep. 2009. PMID: 19148525

4

Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients.

Solomayer EF, Becker S, Pergola-Becker G, Bachmann R, Krämer B, Vogel U, Neubauer H, Wallwiener D, Huober J, Fehm TN. Solomayer EF, et al. Breast Cancer Res Treat. 2006 Jul;98(2):179-84. doi: 10.1007/s10549-005-9147-y. Epub 2006 Mar 22. Breast Cancer Res Treat. 2006. PMID: 16552629

5

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.

Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R, Kasimir-Bauer S. Fehm T, et al. Breast Cancer Res. 2009;11(4):R59. doi: 10.1186/bcr2349. Epub 2009 Aug 10. Breast Cancer Res. 2009. PMID: 19664291 Free PMC article.

6

Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer.

Fehm T, Jäger W, Krämer S, Sohn C, Solomayer E, Wallwiener D, Gebauer G. Fehm T, et al. Among authors: solomayer e. Anticancer Res. 2004 May-Jun;24(3b):1987-92. Anticancer Res. 2004. PMID: 15274389 Free article.

7

Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients.

Becker S, Solomayer E, Becker-Pergola G, Wallwiener D, Fehm T. Becker S, et al. Among authors: solomayer e. Breast Cancer Res Treat. 2007 Dec;106(2):239-43. doi: 10.1007/s10549-006-9484-5. Epub 2007 Jan 27. Breast Cancer Res Treat. 2007. PMID: 17260094

8

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status.

Fehm T, Becker S, Duerr-Stoerzer S, Sotlar K, Mueller V, Wallwiener D, Lane N, Solomayer E, Uhr J. Fehm T, et al. Among authors: solomayer e. Breast Cancer Res. 2007;9(5):R74. doi: 10.1186/bcr1783. Breast Cancer Res. 2007. PMID: 17963511 Free PMC article.

9

Predicting resistance to platinum-containing chemotherapy with the ATP tumor chemosensitivity assay in primary ovarian cancer.

Neubauer H, Stefanova M, Solomayer E, Meisner C, Zwirner M, Wallwiener D, Fehm T. Neubauer H, et al. Among authors: solomayer e. Anticancer Res. 2008 Mar-Apr;28(2A):949-55. Anticancer Res. 2008. PMID: 18507041 Free article.

10

Evaluation of a RT-PCR based routine screening tool for the detection of disseminated epithelial cells in the bone marrow of breast cancer patients.

Becker S, Becker-Pergola G, Banys M, Krawczyk N, Wallwiener D, Solomayer E, Schuetz C, Fehm T. Becker S, et al. Among authors: solomayer e. Breast Cancer Res Treat. 2009 Sep;117(2):227-33. doi: 10.1007/s10549-008-0174-3. Epub 2008 Sep 14. Breast Cancer Res Treat. 2009. PMID: 18791864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters